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Art. 53(b) of the European Patent Convention (EPC) stipulates that 'European patents 
shall not be granted in respect of ... essentially biological processes for the production 
of plants ...'. In two recent decisions,
3
 the Enlarged Board of Appeal (EBoA) of the 
European Patent Office (EPO) has held that 'conventional' plant breeding processes 
involving crossing and selection are 'essentially biological processes' and hence 
unpatentable under Art. 53(b) EPC. 
 
The two cases considered by the EBoA related to European Patent No. 1069819 of 
Plant Bioscience, which had been opposed by the large agrochemical companies 
Syngenta and Limagrain, and European Patent No. 1211926 of the State of Israel 
which had been opposed by the food and chemicals giant Unilever. Both of the 
references to the EBoA were made by Technical Board of Appeal (TBoA) 3.3.04, i.e. 
‘Chemistry IV’. 
 
Following the EBoA's decisions, the appeal proceedings resumed with both patentees 
deleting the claims to plant breeding processes and requesting that their patents be 
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maintained with claims directed to the plant product of the breeding process, i.e. 
broccoli and tomatoes respectively.  
 
In a decision from December 1999,
4
 the EBoA had confirmed that plants could be 
patented as long as the claims were not to plant 'varieties' as such, i.e. defined at the 
lowest taxonomic level. That decision was handed down three months after the 
introduction of Rule 27(b) into the EPC providing that: 'Biotechnological inventions 
shall also be patentable if they concern ... plants or animals if the technical feasibility 
of the invention is not confined to a particular plant or animal variety'. That Rule was 
introduced as part of an attempt by the EPO to bring the EPC into conformity with 
European Union Directive 98/44/EC of July 1998. This Directive did not apply 
automatically to the EPC since, although all EU countries are party to the EPC, the 
EPC is not an EU instrument and several EPC member states are not EU countries.  
 
In the Broccoli case, the opponents indicated that they would not object to the claims 
to the plants and on 13 October 2011 the TBoA cancelled the oral proceedings that 
had been set for the case, thereby suggesting that the Broccoli patent was likely to be 
maintained with those claims. In the Tomatoes case, things did not run so smoothly. 
Oral proceedings were set for 8 November 2011 and, on 10 October 2011, Unilever 
wrote to the TBoA pointing out that, in Unilever's view, the product claims should not 
be allowed 'as it would contravene the intention of the legislators as interpreted by the 
EBoA in G01/08. ... [A]llowing claims having a general format of "A fruit/plant with 
trait x" where the fruit/plant is obtained by a classical breeding method would de facto 
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ignore G01/08'. One of the present authors (Sterckx) followed this with an amicus 
brief supporting Unilever's position.  
 
At the oral proceedings in November, with a freshly appointed chairman, TBoA 
3.3.04 took the unprecedented step of deciding to refer a further set of questions to the 
EBoA to determine whether claims to plants which are the product of an unpatentable 
'essentially biological process' can be allowed. At the time of writing, the TBoA has 
not yet formally made the reference to the EBoA. If claims to the plant product are 
allowable, this would of course render the exclusion of 'essentially biological 
processes' meaningless since those claims would be infringed by the performance of 
the unpatentable process, i.e. the patent would indeed be 'in respect of' the excluded 
process. 
 
In the meantime, the very same point has been considered by the Dutch courts in the 
case Taste of Nature v. Cresco.
5
 In December 2011, Taste of Nature sued Cresco in 
the Dutch courts for infringement of European Patent No. 1290938, the first claim of 
which reads as follows: 
 
A Raphanus sativa plant, obtainable by screening Raphanus sativa [plants for] 
their ability to produce sprouts with at least some purple coloring, selfing 
and/or crossing said plants for several generations and selecting progeny 
having sprouts with purple coloring, characterized in that the sprout of said 
plant comprises anthocyanins at a level of at least 800 nmol per gram fresh 
weight of sprout. 
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Raphanus sativa is radish, and anthocyanins, which are healthy antioxidants, are the 
chemicals that give some flowers and berries their attractive colours. Radish sprouts 
are used for food decoration and in salads. 
 
The Dutch decision, from February 2012, found that the claims of the Radish patent 
were unlikely to be found to be valid. Taste of Nature had argued that the EBoA's 
decisions in the Broccoli and Tomatoes cases did not apply since no ruling was made 
in repect of product claims. The judge disagreed, giving his provisional opinion that 
'it is plausible that under [Art. 53(b) EPC] not only an essentially biological method is 
unpatentable, such as the "classical breeding" in this case, but also a product directly 
obtained by using that method, because a method claim also protects the product 
directly obtained using that method (see [Art. 64(2) EPC]). If it were to be ruled that a 
product-by-process claim is admissible for the directly obtained product of an 
unpatentable essentially biological method, that would render the exclusion in [Art. 
53(b) EPC] as interpreted by the [EBoA] in G1/08 pointless...'. 
 
Art. 64(2) EPC, referred to by the Dutch judge, provides that '[i]f the subject-matter of 
the European patent is a process, the protection conferred by the patent shall extend to 
the products directly obtained by such process’. Thus claims in a European patent that 
are directed to a process will be infringed by dealings with the product obtained 
directly on performance of the process, e.g. by importation of such products from a 
country where they were made, even if there is no corresponding patent in the country 
of manufacture. Otherwise stated, using the language of Art. 53 EPC, a European 
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patent with claims to a process would indeed have been granted ‘in respect of’ the 
direct product of that process. 
 
This, however, is insufficient to show that, where claims to a process are excluded by 
virtue of Art. 53 EPC, then claims to a product which can be made by such a process 
are likewise excluded. Such a conclusion does not even follow if, like Taste of 
Nature’s claims, the product is covered by a so-called ‘product-by-process’ claim 
since the EPO’s standard format for product-by-process claims is ‘product X 
obtainable by process Y’ rather than ‘product X obtained by process Y’. The 
‘obtainable by’ language, favoured by the EPO, ensures that the claim covers the 
product irrespective of the process actually used to make it. Taste of Nature’s claim is 
written in this form. This form allows for the possibility of a product being patentable 
if there is at least one way of making it which is not itself excluded from patentability, 
with the corollary that it will not be patentable if there is no way of making it that is 
not excluded.  
 
This has resonance with  the EBoA’s recent decision on the patentability of 
compositions comprising human embryonic stem cells created following a procedure 
that involved the destruction of early stage human embryos.
6
 Indeed, where a product 
is not itself expressly excluded from patentability and can be made by processes not 
themselves expressly excluded, it would be unreasonable to reject the patentability of 
the product simply because there exists one process for its production which is 
excluded. After all, processes whose commercial exploitation are contrary to morality 
are excluded under Art. 53(a) EPC and for any product it is feasible to think up a 
                                                 
6
 G-2/06 Use of embryos/WARF, Official Journal of the European Patent Office 2009, 306. 
6 
 
process for its preparation that would be contrary to morality, e.g. where slave labour 
is used. 
 
Nonetheless, where the text of a patent or patent application in which a product is 
claimed only provides an explanation as to how to make the product by the use of a 
process deemed unpatentable under Art. 53 EPC, as was the case for the Human 
embryonic stem cell case and as is the case for the Tomatoes, Broccoli and Radish 
patents, then to allow claims to products, obtainable only by the unpatentable 
processes, would de facto mean that such European patents ‘relate to’ the 
unpatentable processes and, in accordance with Art. 53 EPC, should not be granted or 
upheld. Otherwise the intentions of the legislators would be ignored and the 
exclusions rendered ineffective.
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Taste of Nature has appealed in The Netherlands and TBoA 3.3.04’s referral to the 
EBoA is awaited. The next year should see interesting developments in the 
determination of the scope of Art. 53 EPC. 
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